ICAD Earnings & Forecasts

ICAD (ICAD) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

Quarterly Earnings Surprise Amount

Fiscal Quarter	Date Reported	Actual EPS	Estimated EPS	Surprise %
Q1	May 13, 2025	$-0.02	$-0.06	66.7 %
Q4	Mar 19, 2025	$-0.03	$-0.05	40.0 %
Q3	Nov 13, 2024	$-0.07	$-0.08	12.5 %
Q2	Aug 13, 2024	$-0.07	$-0.07	0.00 %

Quarterly Revenue (Billions)

Quarterly Revenue Surprise Amount

Fiscal Quarter	Date Reported	Actual Revenue	Estimated Revenue	Surprise %
Q1	May 13, 2025	$4.87M	$4.53M	7.59 %
Q4	Mar 19, 2025	$5.41M	$4.72M	14.6 %
Q3	Nov 13, 2024	$4.22M	$4.52M	-6.70 %
Q2	Aug 13, 2024	$5.03M	$4.42M	13.8 %

ICAD Guidance

ICAD (ICAD) last issued guidance on January 27, 2025 for Q4 2024. The company guided revenue in the range of $5.1M - $5.3M for the period.

Compared to prior guidance, ICAD lowered its revenue forecast from a prior range of $6.5M - $6.5M.

ICAD has issued 2 guidance updates between March 13, 2023 and January 27, 2025. During this period, the company lowered its outlook 1 time, signaling management's revised expectations.

Recent Earnings Results

Metric	Q1 '25	Q4 '24	Q3 '24	Q2 '24
Earnings Per Share (Non-GAAP)
Estimate	$-0.06	$-0.05	$-0.08	$-0.07
Actual	$-0.02	$-0.03	$-0.07	$-0.07
Surprise	+66.7%	+40.0%	+12.5%	0.00%
Revenue
Estimate	$4.5M	$4.7M	$4.5M	$4.4M
Actual	$4.9M	$5.4M	$4.2M	$5.0M
Surprise	+7.59%	+14.6%	-6.70%	+13.8%

Earnings & Guidance News

PRO
icad Q1 Adj. EPS $(0.02) Beats $(0.06) Estimate, Sales $4.87M Beat $4.53M Estimate

icad (NASDAQ:ICAD) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.06) by 66.67 percent. This is a 60 percent increase over losses of $(0.05) per share from the same period

Benzinga Newsdesk

Nasdaq Down Over 2%; Abbott Laboratories Posts Upbeat Earnings

Avi Kapoor

PRO
icad Q4 2024 Adj. EPS $(0.03) Beats $(0.05) Estimate, Sales $5.408M Beat $4.827M Estimate

icad (NASDAQ:ICAD) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.05) by 40 percent. This is a 50 percent decrease over losses of $(0.02) per share from the same period

Benzinga Newsdesk

Earnings Scheduled For March 19, 2025

Benzinga Insights

PRO
ICAD Expects Q4 2024 Revenue Between $5.1M-$5.3M; Total Annual Recurring Revenue Reaches $9.8M, Up 11% YoY; Closed 106 Deals, Including 19 Cloud Deals

iCAD, Inc. (NASDAQ:ICAD) ("iCAD" or the "Company"), a global leader on a mission to create a world where cancer can't hide by providing clinically proven AI-powered breast health solutions, today reported select

Benzinga Newsdesk

PRO
icad Q3 2024 Adj. EPS $(0.07) Beats $(0.08) Estimate, Sales $4.217M Miss $4.521M Estimate

icad (NASDAQ:ICAD) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.08) by 12.5 percent. The company reported quarterly sales of $4.217 million which missed the analyst

Benzinga Newsdesk

ICAD